As of 2024-12-04, the Intrinsic Value of Repligen Corp (RGEN) is
36.81 USD. This RGEN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 150.54 USD, the upside of Repligen Corp is
-75.50%.
The range of the Intrinsic Value is 25.70 - 75.97 USD
36.81 USD
Intrinsic Value
RGEN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
25.70 - 75.97 |
36.81 |
-75.5% |
| DCF (Growth 10y) |
51.62 - 164.31 |
76.62 |
-49.1% |
| DCF (EBITDA 5y) |
74.05 - 82.81 |
78.16 |
-48.1% |
| DCF (EBITDA 10y) |
106.83 - 130.59 |
117.84 |
-21.7% |
| Fair Value |
-6.71 - -6.71 |
-6.71 |
-104.46% |
| P/E |
(7.96) - 39.05 |
14.41 |
-90.4% |
| EV/EBITDA |
(20.52) - 56.10 |
15.32 |
-89.8% |
| EPV |
31.50 - 40.20 |
35.85 |
-76.2% |
| DDM - Stable |
(3.13) - (12.92) |
(8.03) |
-105.3% |
| DDM - Multi |
37.21 - 119.28 |
56.71 |
-62.3% |
RGEN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
8,434.76 |
| Beta |
0.47 |
| Outstanding shares (mil) |
56.03 |
| Enterprise Value (mil) |
8,172.40 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.94% |
| Cost of Debt |
5.50% |
| WACC |
7.72% |